Symptomatic non-insulin-dependent diabetes mellitus during therapy with recombinant human growth hormone.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8093122.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a 12-year-old girl, hyperglycemia and an elevated glycohemoglobin concentration developed after therapy with growth hormone for familial short stature. Both clinical and biochemical abnormalities disappeared after therapy was discontinued. The insulin response to an oral glucose tolerance test was abnormal 3 months after discontinuation of growth hormone; 18 months later, it remained delayed but was normal quantitatively.
Medical subject headings
- Diabetes Mellitus, Type 2
- Growth Disorders
- Growth Hormone